RENAL CELL CARCINOMA METASTATIC
Clinical trials for RENAL CELL CARCINOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA METASTATIC trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation boost may extend life in kidney cancer that has spread a little
Disease control Recruiting nowThis study tests whether adding precise, high-dose radiation (SBRT) to standard drug therapy (targeted agents and immunotherapy) helps people with kidney cancer that has spread to a few spots (5 or fewer) live longer without the cancer growing. About 252 adults with this type of …
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
Immunotherapy first: landmark trial tests delayed kidney surgery for advanced cancer
Disease control Recruiting nowThis study is for people with kidney cancer that has spread to other parts of the body. It compares two approaches: having surgery to remove the kidney tumor after initial immunotherapy, versus not having surgery at all. The goal is to see if delayed surgery helps patients live l…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: NA • Sponsor: Niels Fristrup • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New antibody aims to stall advanced cancers
Disease control Recruiting nowThis study tests a new drug called OM-RCA-01 in people with several types of cancer that have spread and have a specific marker (FGFR1). The drug is an antibody given by IV every two weeks. The goal is to find a safe dose and see if it can slow tumor growth. About 58 adults with …
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated May 19, 2026 11:52 UTC
-
Blood tests could make kidney cancer drugs safer and more effective
Knowledge-focused Recruiting nowThis study looks at 200 people with advanced kidney cancer to see if measuring drug levels in the blood can help doctors choose the right dose, reduce side effects, and improve survival. Researchers will also check how genes and immune responses affect treatment success. The goal…
Matched conditions: RENAL CELL CARCINOMA METASTATIC
Sponsor: Niels Fristrup • Aim: Knowledge-focused
Last updated May 26, 2026 11:18 UTC